Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 9
2005 11
2006 10
2007 17
2008 7
2009 11
2010 14
2011 6
2012 6
2013 9
2014 15
2015 13
2016 20
2017 16
2018 5
2019 8
2020 10
2021 16
2022 11
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean marien de jonge (174 results)?
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Lezaic L, Erba PA, Decristoforo C, Zaletel K, Mikolajczak R, Maecke H, Maina T, Konijnenberg M, Kolenc P, Trofimiuk-Müldner M, Przybylik-Mazurek E, Virgolini I, de Jong M, Fröberg AC, Rangger C, Di Santo G, Skorkiewicz K, Garnuszek P, Solnica B, Nock BA, Fedak D, Gaweda P, Hubalewska-Dydejczyk A. Lezaic L, et al. Among authors: de jong m. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):892-907. doi: 10.1007/s00259-022-05992-6. Epub 2022 Nov 5. Eur J Nucl Med Mol Imaging. 2023. PMID: 36334104 Free PMC article. Clinical Trial.
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity.
Ruigrok EAM, Verhoeven M, Konijnenberg MW, de Blois E, de Ridder CMA, Stuurman DC, Bertarione L, Rolfo K, de Jong M, Dalm SU. Ruigrok EAM, et al. Among authors: de jong m. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4440-4451. doi: 10.1007/s00259-022-05926-2. Epub 2022 Aug 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 35951084 Free PMC article.
Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T.
Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: de jong m. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3956-3957. doi: 10.1007/s00259-022-05845-2. Eur J Nucl Med Mol Imaging. 2022. PMID: 35614268 Free PMC article. No abstract available.
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: de jong m. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638. doi: 10.1007/s00259-022-05821-w. Epub 2022 May 12. Eur J Nucl Med Mol Imaging. 2022. PMID: 35556158 Free PMC article.
206 results